Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease (NCT07187466)
Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of this study is to learn about different treatments for overactive bladder symptoms in Parkinson's Disease. The investigators want to find out if people who do not respond to one treatment (either behavioral or drug treatment) will respond to combined treatment. The investigators also want to find out what factors influence whether someone responds to the treatments.
Who can join: Review the eligibility criteria below.
Location: Atlanta VA Medical and Rehab Center, Decatur, GA โ Decatur, Georgia
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (3 Sites)
- Atlanta VA Medical and Rehab Center, Decatur, GA โ Decatur, Georgia
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA โ Philadelphia, Pennsylvania
- VA Salt Lake City Health Care System, Salt Lake City, UT โ Salt Lake City, Utah
๐ Contact the Study Coordinator
Phone: (404) 321-1611
Email: Taressa.Sergent@va.gov
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overactive Bladder
- Reduced-dose Botox for Urgency Incontinence Among Elder Females โ Birmingham, Alabama
- Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections โ Louisville, Kentucky
- A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections โ Cincinnati, Ohio
- Add-On ZIDA Sock Therapy for Overactive Bladder โ Charleston, South Carolina
- Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder โ Bethesda, Maryland
Explore by condition: All Overactive Bladder clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.